Hösel, M.* ; Quasdorff, M.* ; Ringelhan, M. ; Kashkar, H.* ; Debey-Pascher, S.* ; Sprinzl, M.F. ; Bockmann, J.H. ; Arzberger, S. ; Webb, D.* ; von Olshausen, G.* ; Weber, A.* ; Schultze, J.L.* ; Büning, H.* ; Heikenwälder, M. ; Protzer, U.
     
    
        
Hepatitis B virus activates signal transducer and activator of transcription 3 supporting hepatocyte survival and virus replication.
    
    
        
    
    
        
        Cell. Mol. Gast. Hept. 4, 339-363 (2017)
    
    
    
      
      
	
	    Background & Aims The human hepatitis B virus (HBV) is a major cause of chronic hepatitis and hepatocellular carcinoma (HCC), but molecular mechanisms driving liver disease and carcinogenesis are largely unknown. We therefore studied cellular pathways altered by HBV infection. Methods We performed gene expression profiling of primary human hepatocytes (PHH) infected with HBV and proved the results in HBV-replicating cell lines and human liver tissue using real time PCR and Western blotting. Activation of signal transducer and activator of transcription (STAT3) was examined in HBV-replicating human hepatocytes, HBV-replicating mice and liver tissue from HBV-infected individuals using Western blotting, STAT3-luciferase reporter assay, and immunohistochemistry. The consequences of STAT3 activation on HBV infection and cell survival were studied by chemical inhibition of STAT3 phosphorylation and siRNA-mediated knockdown of STAT3. Results Gene expression profiling of HBV-infected PHH detected no interferon response, while genes encoding for acute phase and anti-apoptotic proteins were up-regulated. This gene regulation was confirmed in liver tissue samples of patients with chronic HBV infection and in HBV-related HCC. Pathway analysis revealed activation of STAT3 to be the major regulator. Interleukin-6-dependent and -independent activation of STAT3 was detected in HBV-replicating hepatocytes in cell culture and in vivo. Prevention of STAT3 activation by inhibition of Janus tyrosine kinases as well as siRNA-mediated knockdown of STAT3 induced apoptosis and reduced HBV replication and gene expression. Conclusions HBV activates STAT3 signaling in hepatocytes to foster its own replication but also to prevent apoptosis of infected cells. This very likely supports HBV-related carcinogenesis.  
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
    
        Thesis type
        
    
 
    
        Editors
        
    
    
        Keywords
        hepatitis B virus infection, STAT3 signaling, hepatocellular carcinoma, apoptosis
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2017
    
 
    
        Prepublished in Year
        
    
 
    
        HGF-reported in Year
        2017
    
 
    
    
        ISSN (print) / ISBN
        2352-345X
    
 
    
        e-ISSN
        2352-345X
    
 
    
        ISBN
        
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 4,  
	    Issue: 3,  
	    Pages: 339-363 
	    Article Number: ,  
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            Elsevier
        
 
        
            Publishing Place
            New York, NY
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        
    
 
     
    
        POF-Topic(s)
        30203 - Molecular Targets and Therapies
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
    
 
    
        Research field(s)
        Immune Response and Infection
    
 
    
        PSP Element(s)
        G-502700-003
G-551600-001
    
 
    
        Grants
        
    
 
    
        Copyright
        
    
 	
    
    
    
        Erfassungsdatum
        2017-07-24